Latest Feature

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

CardioMEMS took 11 years to pay off, but for Boston Millennia it was worth it

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Podcast: Haemonetics CEO Brian Concannon at MassDevice.com's DeviceTalks

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for August 21, 2014

August 21, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Nobel Biocare's Q2 profits double as it fields buyout interest

August 21, 2014 by Brad Perriello

Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.

Nobel Biocare's Q2 profits double as it fields buyout interest

Claret Medical chases FDA win with $18M Series B for cerebral protection device

August 21, 2014 by Arezu Sarvestani

California device maker Claret Medical plans to use its new funds to complete a U.S. pivotal trial of its Sentinel cerebral protection system.

Claret Medical chases FDA win with up to $18M raised in Series B

Claret Medical said today that it secured up to $18 million in Series B financing it plans to use to make progress toward the U.S. market.

Intuitive Surgical wins FDA OK for Firefly imaging

August 21, 2014 by Arezu Sarvestani

All new da Vinci systems will ship with Intuitive Surgical's newly cleared Firefly blood and tissue imaging technology.

Intuitive Surgical wins FDA OK for da Vinci imaging feature

Retractable Technologies urges appeals court to leave infringement win over BD alone

August 21, 2014 by Brad Perriello

Retractable Technologies urges a federal appeals court to deny Becton Dickinson's bid for a re-hearing of its $7.7 million patent infringement loss.

Retractable Technologies urges appeals court to leave its win over BD alone

FDA OKs return of Covidien's Pipeline embolism device

August 21, 2014 by Brad Perriello

Covidien says it plans to get its recalled Pipeline brain embolism device back on the market immediately, after the FDA approved manufacturing changes aimed at correcting the problem that prompted the recall.

FDA OKs return of Covidien's Pipeline embolism device

Invacare to cut another 190 workers amid tough year

August 21, 2014 by Arezu Sarvestani

Invacare blames a poor 1st-half and "slow start" to Q3 for restructuring measures that will reduce its workforce by nearly 200 employees.

Invacare to cut 200 workers after a slow year

Ohio-based Invacare (NYSE:IVC) is conducting another round of layoffs as it continues to struggle through the year.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp